These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15380200)

  • 1. 5-Carboxamido-1,3,2-dioxaphosphorinanes, potent inhibitors of MTP.
    Sulsky R; Robl JA; Biller SA; Harrity TW; Wetterau J; Connolly F; Jolibois K; Kunselman L
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5067-70. PubMed ID: 15380200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.
    Stern E; Muccioli GG; Bosier B; Hamtiaux L; Millet R; Poupaert JH; Hénichart JP; Depreux P; Goossens JF; Lambert DM
    J Med Chem; 2007 Nov; 50(22):5471-84. PubMed ID: 17915849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzimidazole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
    Borza I; Kolok S; Gere A; Nagy J; Fodor L; Galgóczy K; Fetter J; Bertha F; Agai B; Horváth C; Farkas S; Domány G
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4638-40. PubMed ID: 16782335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase.
    Greco MN; Hawkins MJ; Powell ET; Almond HR; de Garavilla L; Hall J; Minor LK; Wang Y; Corcoran TW; Di Cera E; Cantwell AM; Savvides SN; Damiano BP; Maryanoff BE
    J Med Chem; 2007 Apr; 50(8):1727-30. PubMed ID: 17361995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel series of highly potent benzimidazole-based microsomal triglyceride transfer protein inhibitors.
    Robl JA; Sulsky R; Sun CQ; Simpkins LM; Wang T; Dickson JK; Chen Y; Magnin DR; Taunk P; Slusarchyk WA; Biller SA; Lan SJ; Connolly F; Kunselman LK; Sabrah T; Jamil H; Gordon D; Harrity TW; Wetterau JR
    J Med Chem; 2001 Mar; 44(6):851-6. PubMed ID: 11300866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and structure-activity relationships of ortho-biphenyl carboxamides as potent Smoothened antagonists inhibiting the Hedgehog signaling pathway.
    Peukert S; Jain RK; Geisser A; Sun Y; Zhang R; Bourret A; Carlson A; Dasilva J; Ramamurthy A; Kelleher JF
    Bioorg Med Chem Lett; 2009 Jan; 19(2):328-31. PubMed ID: 19091559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diarylacetylene piperidinyl amides as novel anxiolytics.
    Kordik CP; Luo C; Gutherman M; Vaidya AH; Rosenthal DI; Crooke JJ; McKenney SL; Plata-Salaman CR; Reitz AB
    Bioorg Med Chem Lett; 2006 Jun; 16(11):3065-7. PubMed ID: 16580201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel isoxazole carboxamides as growth hormone secretagogue receptor (GHS-R) antagonists.
    Liu B; Liu G; Xin Z; Serby MD; Zhao H; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5223-6. PubMed ID: 15380232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsomal triglyceride transfer protein inhibitors: discovery and synthesis of alkyl phosphonates as potent MTP inhibitors and cholesterol lowering agents.
    Magnin DR; Biller SA; Wetterau J; Robl JA; Dickson JK; Taunk P; Harrity TW; Lawrence RM; Sun CQ; Wang T; Logan J; Fryszman O; Connolly F; Jolibois K; Kunselman L
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1337-40. PubMed ID: 12657277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proline bis-amides as potent dual orexin receptor antagonists.
    Bergman JM; Roecker AJ; Mercer SP; Bednar RA; Reiss DR; Ransom RW; Meacham Harrell C; Pettibone DJ; Lemaire W; Murphy KL; Li C; Prueksaritanont T; Winrow CJ; Renger JJ; Koblan KS; Hartman GD; Coleman PJ
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1425-30. PubMed ID: 18207395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective synthesis and structure-activity relationship of novel ceramide trafficking inhibitors. (1R,3R)-N-(3-hydroxy-1-hydroxymethyl-3-phenylpropyl)dodecanamide and its analogues.
    Nakamura Y; Matsubara R; Kitagawa H; Kobayashi S; Kumagai K; Yasuda S; Hanada K
    J Med Chem; 2003 Aug; 46(17):3688-95. PubMed ID: 12904073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
    Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
    J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3.
    Hayes ME; Breinlinger EC; Wallace GA; Grongsaard P; Miao W; McPherson MJ; Stoffel RH; Green DW; Roth GP
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2414-9. PubMed ID: 18337097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,7-Diazadibenzophosphole oxide: a phosphorus-bridged viologen analogue with significantly lowered reduction threshold.
    Durben S; Baumgartner T
    Angew Chem Int Ed Engl; 2011 Aug; 50(34):7948-52. PubMed ID: 21732507
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
    Wang H; Ruan Z; Li JJ; Simpkins LM; Smirk RA; Wu SC; Hutchins RD; Nirschl DS; Van Kirk K; Cooper CB; Sutton JC; Ma Z; Golla R; Seethala R; Salyan ME; Nayeem A; Krystek SR; Sheriff S; Camac DM; Morin PE; Carpenter B; Robl JA; Zahler R; Gordon DA; Hamann LG
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3168-72. PubMed ID: 18485702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure.
    Leopoldo M; Lacivita E; Colabufo NA; Contino M; Berardi F; Perrone R
    J Med Chem; 2005 Dec; 48(25):7919-22. PubMed ID: 16335915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation.
    DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Chai L; Chaffee SC; Deak HL; Epstein LF; Faust T; Gallant P; Gore A; Gu Y; Henkle B; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; Zhao H; Zhu L; Zhu X
    J Med Chem; 2008 Mar; 51(6):1681-94. PubMed ID: 18321037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-anilino-5-carboxamido-2-pyridone derivatives as noncompetitive inhibitors of mitogen-activated protein kinase kinase.
    Spicer JA; Rewcastle GW; Kaufman MD; Black SL; Plummer MS; Denny WA; Quin J; Shahripour AB; Barrett SD; Whitehead CE; Milbank JB; Ohren JF; Gowan RC; Omer C; Camp HS; Esmaeil N; Moore K; Sebolt-Leopold JS; Pryzbranowski S; Merriman RL; Ortwine DF; Warmus JS; Flamme CM; Pavlovsky AG; Tecle H
    J Med Chem; 2007 Oct; 50(21):5090-102. PubMed ID: 17880056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl.
    Alper PB; Liu H; Chatterjee AK; Nguyen KT; Tully DC; Tumanut C; Li J; Harris JL; Tuntland T; Chang J; Gordon P; Hollenbeck T; Karanewsky DS
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1486-90. PubMed ID: 16412634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of piperidine carboxamide TRPV1 antagonists.
    Cheung WS; Calvo RR; Tounge BA; Zhang SP; Stone DR; Brandt MR; Hutchinson T; Flores CM; Player MR
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4569-72. PubMed ID: 18662879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.